Product Information
DROXIDOPA 300 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $2.2457 per EA under NDC 59651037790. Its NADAC has been published 114 times since Jun 21, 2023.
The High Outlier badge above means this manufacturer's average price in the Droxidopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651037790
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
DROXIDOPAApproval Type
Generic (ANDA)
FDA Application
ANDA214387On Market Since
2/18/2021
Pharmacological Classes
Price Statistics
The NADAC for DROXIDOPA 300 MG CAPSULE has been published 114 times since Jun 21, 2023, and over the history we have for it it has declined 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2457 per EA |
|---|---|
| All-time high | $3.0478 (Nov 13, 2024) |
| All-time low | $2.2338 (Jul 23, 2025) |
| 52-week high | $2.3074 |
| 52-week low | $2.2338 |
| Median price | $2.5551 |
| Average price | $2.5954 |
| Largest weekly change | +12.0% (Aug 21, 2024) |
| Weeks tracked | 114 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DROXIDOPA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 300 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $2.2457 per EA (NDC 59651037790), effective Aug 20, 2025.
How has the price of DROXIDOPA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DROXIDOPA 300 MG CAPSULE has declined 12.1%. It has been tracked across 114 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for DROXIDOPA 300 MG CAPSULE?
Since Jun 21, 2023, the NADAC for DROXIDOPA 300 MG CAPSULE has ranged from a low of $2.2338 (Jul 23, 2025) to a high of $3.0478 (Nov 13, 2024), with a median of $2.5551 per EA.
Are there cheaper alternatives to DROXIDOPA 300 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as DROXIDOPA 300 MG CAPSULE, but none are currently priced below it.
Who manufactures DROXIDOPA 300 MG CAPSULE?
DROXIDOPA 300 MG CAPSULE (NDC 59651037790) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification